Sources | Names Used |
---|---|
CTRPv2 | PRL-3 inhibitor I |
PharmacoGx | PRL-3 Inhibitor I |
Database | Identifier |
---|---|
Smiles: | Brc1ccc(OCc2ccccc2Br)c(/C=C3/SC(=S)NC3=O)c1 |
Pubchem: | 11983303 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PPP2R5E | CTRPv2 | pan-cancer | AAC | 0.071 | 0.07 |
mRNA | NABP1 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.07 |
mRNA | ZNF429 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.07 |
mRNA | ADH5 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.07 |
mRNA | SHOC2 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.07 |
mRNA | TTC21A | CTRPv2 | pan-cancer | AAC | 0.068 | 0.07 |
mRNA | E2F6 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.07 |
mRNA | NAA10 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.07 |
mRNA | CNOT4 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.07 |
mRNA | NAP1L4 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.07 |